The Mammotome brand has a long history in the minimally invasive breast biopsy market.
In 1995, Mammotome® was introduced as the first vacuum-assisted biopsy system. Two years later, the Mammotome® Biopsy System was acquired by Ethicon Endo-Surgery (EES), a Breast Care Business of Johnson & Johnson. Since then, additional image-guided products were introduced and the Mammotome brand became the market leader. Over 4 million women worldwide have had an image-guided, minimally invasive breast biopsy using the Mammotome® Biopsy System.
In July 2010, Devicor® Medical Products, Inc. acquired the Breast Care Business from Johnson & Johnson. Devicor Medical Products is led by a senior management team of healthcare executives with over 150 combined years of cross-functional experience in global healthcare companies. As a young company with a strong future, Devicor Medical Products is focused exclusively on medical technologies that improve patient experiences and outcomes.
After acquiring the Breast Care Business, Devicor leveraged the Mammotome brand to subsequently form Mammotome, a division of Devicor® Medical Products, Inc. Mammotome is headquartered in Cincinnati, Ohio, and the Mammotome brand is marketed in over 50 countries globally.
Today, Mammotome remains committed to its heritage of advancing technology for early detection of breast cancer; providing support and education for clinicians worldwide; and offering breast care information for patients.